New Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing
FCS medical oncologist and hematologist Ernesto Bustinza-Linares, MD is co-author of a recent abstract published in the American Society of Clinical Oncology Journal, "JCO Precision Oncology".
Fort Myers, Fla., April 25, 2024 –
“We cannot stress enough the importance of research in the oncology field,” says FCS President & Managing Physician
The abstract’s authors address the limitations of existing guidelines that recommend checkpoint immunotherapy, sometimes in combination with chemotherapy, for treating NSCLC, which often discounts patient variability and immune factors. Using a new machine-learning test for pretreated plasma proteomic profiles, PROphet, the authors were able to identify levels of protein inhibitors for each patient to determine the best line of treatment.
The findings from the study show that by incorporating additional plasma proteome-based testing, combined with the standard protein inhibitor testing, clear differences in patient outcomes were observed after applying targeted treatments based on the testing results.
“We can no longer apply a blanketed approach to oncology care,” says Dr. Bustinza. “This study is pivotal in developing a precise approach to treating cancer based on the unique cellular properties of the patient, not the cancer type. With this knowledge, we can then apply the best possible approach, in this instance, choosing a monotherapy or combination therapy, to drive optimal results.”
To read the full abstract, visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- NCPA Announces Keynote Speaker for Annual Convention
September 18th 2025
- Upcoming NCPA Items for Pharmacy Teams: September and October 2025
September 11th 2025
- NCPA Applauds FTC Pick for Associate Director of Health Care
September 10th 2025
- NCPA Leads Huge Coalition in Letter Asking Congress to Pass PBM Reform Act
September 8th 2025